Oxford Medical Products’ Sirona inert dual-polymer hydrogel pill can result in 10% TBWL
Oxford Medical Products has announced positive topline results from the first randomised controlled trial (RCT) of Sirona, its...
top of page
Browse by category
Search
OMP begins first human trial of self-expanding hydrogel capsule Sirona
Oxford Medical Products (OMP) has initiated the first human trial of Sirona, its self-expanding hydrogel capsule which aims to deliver a...
Oxford Medical Products gains £2.5 million funding for weight-loss hydrogel technology
Oxford Medical Products has raised £2.5M in equity investment to conduct the first human trials of Sirona, its weight-loss platform....
Browse by tag
bottom of page